The group’s principle activity is to develop a therapeutic medical device. The group’s products include AuroShell(TM) microparticles and AuroLase(TM) cancer therapy. Customers served by the group include cancer therapy and imaging, drug delivery, micro fluidics and diagnostic. The group operates from United States.